+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cold & Flu Supplements Market by Type (Herbal Extracts, Homeopathic, Natural Molecules), Form (Pills & Capsules, Powders, Syrups), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5888660
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cold & Flu Supplements Market size was estimated at USD 16.78 billion in 2023, USD 18.57 billion in 2024, and is expected to grow at a CAGR of 10.90% to reach USD 34.65 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cold & Flu Supplements Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cold & Flu Supplements Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cold & Flu Supplements Market, highlighting leading vendors and their innovative profiles. These include Amway International Inc., Bayer AG, Church & Dwight Co., Inc., GlaxoSmithKline PLC, Haleon PLC, Himalaya Global Holdings Ltd., Johnson & Johnson Services Inc., Medique Products, Mondelez Global LLC, Nature’s Sunshine Products, Inc., Nature’s Way, Inc., Neurobiologix, Inc., Nutraceutical Corporation, Perrigo Company PLC, Reckitt Benckiser Group PLC, Sambucol by PharmaCare Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., The Menarini Group, The Procter & Gamble Company, Thornton and Ross Limited by STADA Group, and Wakunaga Pharmaceutical Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Cold & Flu Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Herbal Extracts
    • Homeopathic
    • Natural Molecules
    • Vitamins & Minerals
  • Form
    • Pills & Capsules
    • Powders
    • Syrups
  • Distribution Channel
    • Online & E-commerce Platforms
    • Pharmacies & Drug Stores
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cold & Flu Supplements Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cold & Flu Supplements Market?
  3. What are the technology trends and regulatory frameworks in the Cold & Flu Supplements Market?
  4. What is the market share of the leading vendors in the Cold & Flu Supplements Market?
  5. Which modes and strategic moves are suitable for entering the Cold & Flu Supplements Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cold & Flu Supplements Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Seasonal disease outbreaks and concerns about immune health of aging population
5.1.1.2. Rising consumer awareness through government health programs and initiatives
5.1.1.3. Emerging preferences for natural and herbal supplements
5.1.2. Restraints
5.1.2.1. Wider availability of pharmaceutical alternatives
5.1.3. Opportunities
5.1.3.1. Ongoing introduction of newly developed immunity booster supplements
5.1.3.2. Growing expansion of supermarkets and online distribution channels
5.1.4. Challenges
5.1.4.1. Challenges associated with maintaining product quality and adhering to regulatory requirements
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cold & Flu Supplements Market, by Type
6.1. Introduction
6.2. Herbal Extracts
6.3. Homeopathic
6.4. Natural Molecules
6.5. Vitamins & Minerals
7. Cold & Flu Supplements Market, by Form
7.1. Introduction
7.2. Pills & Capsules
7.3. Powders
7.4. Syrups
8. Cold & Flu Supplements Market, by Distribution Channel
8.1. Introduction
8.2. Online & E-commerce Platforms
8.3. Pharmacies & Drug Stores
9. Americas Cold & Flu Supplements Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cold & Flu Supplements Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cold & Flu Supplements Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Amway International Inc.
13.1.2. Bayer AG
13.1.3. Church & Dwight Co., Inc.
13.1.4. GlaxoSmithKline PLC
13.1.5. Haleon PLC
13.1.6. Himalaya Global Holdings Ltd.
13.1.7. Johnson & Johnson Services Inc.
13.1.8. Medique Products
13.1.9. Mondelez Global LLC
13.1.10. Nature’s Sunshine Products, Inc.
13.1.11. Nature’s Way, Inc.
13.1.12. Neurobiologix, Inc.
13.1.13. Nutraceutical Corporation
13.1.14. Perrigo Company PLC
13.1.15. Reckitt Benckiser Group PLC
13.1.16. Sambucol by PharmaCare Laboratories Pty Ltd.
13.1.17. Sun Pharmaceutical Industries Ltd.
13.1.18. The Menarini Group
13.1.19. The Procter & Gamble Company
13.1.20. Thornton and Ross Limited by STADA Group
13.1.21. Wakunaga Pharmaceutical Co., Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. COLD & FLU SUPPLEMENTS MARKET RESEARCH PROCESS
FIGURE 2. COLD & FLU SUPPLEMENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COLD & FLU SUPPLEMENTS MARKET DYNAMICS
FIGURE 7. COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COLD & FLU SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. COLD & FLU SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amway International Inc.
  • Bayer AG
  • Church & Dwight Co., Inc.
  • GlaxoSmithKline PLC
  • Haleon PLC
  • Himalaya Global Holdings Ltd.
  • Johnson & Johnson Services Inc.
  • Medique Products
  • Mondelez Global LLC
  • Nature’s Sunshine Products, Inc.
  • Nature’s Way, Inc.
  • Neurobiologix, Inc.
  • Nutraceutical Corporation
  • Perrigo Company PLC
  • Reckitt Benckiser Group PLC
  • Sambucol by PharmaCare Laboratories Pty Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • The Menarini Group
  • The Procter & Gamble Company
  • Thornton and Ross Limited by STADA Group
  • Wakunaga Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Table Information